Artwork
iconShare
 
Manage episode 518811476 series 2826750
Content provided by Becker's Healthcare. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Becker's Healthcare or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. He shares emerging trends in AI and healthcare, the growing potential of individualized therapies, and his advice for passionate leaders driving innovation in the field.

  continue reading

529 episodes